64P Assessment of clinical benefit of cancer drugs recommended in National Comprehensive Cancer Centre (NCCN) guidelines for advanced gastrointestinal stromal tumors (GIST)
ESMO Open(2024)
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要
ESMO Open(2024)